BRAINBITES

WEEK OF FEB 2โ€“8, 2026 ยท ISSUE 1

BRAINBITES ย โ€” Your weekly health, fitness, and longevity digest. Five minutes that cover the highest-signal podcasts and science before they hit the mainstream.

This week: neuroscientist Read Montague walked Huberman through the dopamine prediction-error system that runs every decision you make, Ido Portal reappeared in the Essentials vault with a movement philosophy that treats the body as a skill, and a Nature Medicine study on GLP-1 drugs landed a cognitive side-effect finding no one expected.

From: Huberman Lab ยท Huberman Lab Essentials

๐Ÿ”ข The prediction error that runs 80% of your daily decisions

๐ŸŽ™๏ธ Read Montague on dopamine, serotonin, and computational models of choice

๐Ÿ’ก Deep Dive: why your reward system is a ledger, not a switch

๐Ÿ“ฐ News Bits: GLP-1 drugs and cognition ยท movement as a practice ยท the serotonin rebalance

GM.

The episode most worth your time this week was Read Montague on Huberman. Montague studies dopamine computationally โ€” not what it feels like, but what it calculates. The distinction matters more than most health podcasts acknowledge. Your reward system isn't a feeling. It's a running account of how reality compared to expectation, updated thousands of times a day.

โฑ ~5 min read

๐Ÿง  THE REWARD LEDGER

What your brain is actually tracking when it says 'want.'

Two ideas surfaced in the same week. One: the dopamine system doesn't track pleasure โ€” it tracks prediction errors, the gap between what you expected and what you got. Two: the body isn't a machine you maintain. It's a skill you practice. One came from computational neuroscience. The other from a man who treats a handstand the way a musician treats a scale.

The thread this week: the systems that run you are learning systems โ€” and most people have never looked at the curriculum.

๐Ÿ”ข THE VITAL SIGN ยท NEUROSCIENCE / DECISION-MAKING

80%
The estimated share of daily decisions driven by dopamine prediction-error signalling rather than conscious deliberation.

Read Montague walked Huberman through the computational neuroscience behind dopamine โ€” not the pop-science version where dopamine equals pleasure, but the engineering version where dopamine encodes prediction errors. When you get something better than expected, dopamine spikes. When you get exactly what you expected, it stays flat. When reality disappoints, it dips. The system isn't rewarding you. It's teaching you.

Montague's lab has mapped this signal across decision tasks, addiction models, and social exchanges. The core finding: the brain doesn't optimise for happiness. It optimises for prediction accuracy. The dopamine spike isn't the reward โ€” it's the error signal that updates the model. Over thousands of repetitions, your preferences, habits, and cravings are all downstream of this update loop.

The serotonin system, Montague argued, operates on a different timescale โ€” tracking slower, mood-level baselines that modulate how aggressively the dopamine system updates. When serotonin is low, prediction errors hit harder. When it's stable, the system learns more evenly.

The implication for anyone trying to change a habit: you're not fighting willpower. You're fighting a prediction model that's been training on your behaviour for decades.

Dr. Read Montague on Huberman Lab ยท February 2, 2026

๐ŸŽ™๏ธ THE EPISODE ยท NEUROSCIENCE / MOTIVATION

The dopamine system doesn't care what you want โ€” it cares what you predicted
Read Montague on computational models of dopamine, serotonin, and why your brain treats every outcome as a data point.
Dr. Read Montague ยท Huberman Lab ยท February 2, 2026

Montague is a computational neuroscientist at Virginia Tech, not a wellness figure, and it shows. The conversation is dense but precise. Huberman lets him run, and the result is one of the clearest explanations of reward-prediction error you'll find outside a textbook.

Prediction error, not pleasure.

The dopamine signal that fires when you eat something delicious isn't encoding 'this is good.' It's encoding 'this was better than I expected.' If you ate the same meal every day, the signal would flatten to zero โ€” not because the food got worse, but because the prediction caught up. Montague's point: dopamine drives learning, not enjoyment. The distinction explains why the tenth bite is never as good as the first, and why novelty-seeking isn't a personality trait โ€” it's a computational necessity.

๐ŸŽ™๏ธ Skip to ~18:00 for the prediction-error model explained with a coffee analogy that makes it click.

Serotonin as the learning-rate dial.

If dopamine is the error signal, serotonin modulates how much the brain adjusts in response. Low serotonin means the system over-reacts to every disappointment and every windfall. High serotonin means steadier updates. Montague's framing: SSRIs don't make you happy. They slow the learning rate, which reduces the volatility of mood. The effect looks like calm, but the mechanism is mathematical.

Social dopamine is the highest-bandwidth channel.

Montague's fMRI work shows that social interactions generate some of the largest and most sustained prediction-error signals the brain produces. A compliment from a stranger, a betrayal by a friend, a competitive win โ€” each one updates the model in ways that no solo activity matches. His argument: loneliness isn't just emotionally costly. It's computationally impoverishing. The brain has fewer errors to learn from, and the model stagnates.

๐ŸŽ™๏ธ Listen โ†’ Huberman Lab, Dr. Read Montague, February 2, 2026

๐Ÿ’ก DEEP DIVE ยท THE LEARNING BRAIN

Montague gives you the mechanism. The week gives you the question: what is your prediction model trained on?

The pop-science version of dopamine is a motivation molecule โ€” hack it with cold plunges, fasting, and dopamine detoxes. Montague's version is stranger and more useful. Dopamine is a teaching signal. Every craving, every habit, every preference you have is the downstream output of a model that's been updating itself since birth.

The practical consequence: if you want to change behaviour, changing the reward doesn't work well. What works is changing the prediction. Montague's lab has shown that reframing expectations before an experience can shift the dopamine response to that experience. Cognitive behavioural therapy, he suggests, works partly because it rewrites the predictions the brain is testing against reality.

Ido Portal's Essentials episode, which Huberman pulled from the vault the same week, lands on the same idea from a different angle. Portal doesn't talk about dopamine. He talks about practice. But his core argument โ€” that the body is a skill you develop, not a vehicle you maintain โ€” maps onto the prediction-error framework surprisingly well. A movement practice that constantly introduces new challenges keeps the prediction model updating. A routine that never changes lets it calcify.

The GLP-1 finding from Nature Medicine adds a pharmacological wrinkle. Semaglutide appears to reduce not just appetite but compulsive behaviours across multiple domains โ€” food, alcohol, shopping. If the dopamine prediction-error model is correct, GLP-1 drugs may be dampening the error signal itself, not just the hunger signal. The mechanism is still speculative, but the pattern is consistent.

The question this week isn't whether your dopamine system is working. It's what curriculum you've been feeding it โ€” and whether that curriculum is still serving you.

๐Ÿ“ฐ NEWS BITS

GLP-1 drugs may quiet compulsive behaviour across domains โ€” not just appetite.

A Nature Medicine analysis of insurance-claims data covering 1.2 million patients on semaglutide found statistically significant reductions in alcohol use disorder diagnoses, compulsive shopping behaviour, and nicotine dependence โ€” none of which are approved indications. The effect sizes were modest (12โ€“18% relative risk reductions) but consistent. The authors' hypothesis: GLP-1 receptors in the mesolimbic dopamine pathway may modulate reward signalling broadly, not just for food. The grain of salt: claims data can't distinguish causation from selection effects. People who start semaglutide may differ in ways the study can't control for.

โ€” Nature Medicine, February 2026

Movement is a practice, not a workout โ€” Ido Portal's case for treating your body like an instrument.

Huberman pulled Portal's Essentials episode from the archive the same week as the Montague interview, and the pairing is surprisingly apt. Portal's philosophy: stop asking 'what exercise should I do?' and start asking 'what can my body do that it couldn't last month?' The framework privileges novelty, complexity, and skill acquisition over sets and reps. The research Portal cites on motor learning and neuroplasticity is real โ€” novel movement challenges generate cortical reorganisation that repetitive exercise does not.

โ€” Huberman Lab Essentials, Ido Portal, February 5, 2026

The serotonin rebalance: why SSRIs take weeks and what that delay tells us.

Montague's serotonin framing โ€” that it modulates learning rate, not mood directly โ€” offers a clean explanation for the SSRI delay that puzzles patients. If SSRIs slow the prediction-error update rate, the brain needs weeks of accumulated lower-volatility updates before the overall model stabilises. The mood improvement isn't the drug kicking in. It's the model gradually converging on steadier predictions. The clinical implication: the first two weeks aren't a waiting period. They're active recalibration.

โ€” Huberman Lab, Dr. Read Montague, February 2, 2026

P.S. If you could see your dopamine prediction-error log for the past week โ€” every spike, every dip โ€” what would surprise you most? Hit reply and tell us. Best responses go in a future issue.

What did you think of today's BrainBite?

๐Ÿง ๐Ÿง ๐Ÿง ๐Ÿง ๐Ÿง  ย  Sent this to my therapist mid-read

๐Ÿง ๐Ÿง ๐Ÿง  ย  The Montague stuff is gold. Need to re-read the serotonin section.

๐Ÿง  ย  Too computational. Give me protocols.

We listen to every health podcast so you don't have to. Weekly. No noise.

Your brain is keeping score whether you check the ledger or not. See you next week.